Lineage Cell Therapeutics... (LCTX)
0.42
0.00 (0.65%)
At close: Apr 04, 2025, 11:54 AM
Lineage Cell Therapeutics Revenue
Lineage Cell Therapeutics reported an annual revenue of $9.5M, reflecting a 6.19% growth. For the quarter ending December 31, 2024, Lineage Cell Therapeutics generated $2.87M in revenue.
Revenue (ttm)
$9.5M
Revenue Growth
6.19%
Price / Sales Ratio
10.59
Revenue / Employee
$135.7K
Employees
70
Market Cap
95.89M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 9.5M | +6.19% |
| Dec 31, 2023 | 8.95M | -39.16% |
| Dec 31, 2022 | 14.7M | +277.39% |
| Dec 31, 2021 | 3.9M | +404.01% |
| Dec 31, 2020 | 773K | n/a |